ProfileGDS4718 / 234351_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 51% 79% 53% 54% 52% 57% 57% 44% 47% 49% 56% 52% 55% 57% 55% 53% 57% 61% 64% 55% 52% 49% 45% 51% 51% 54% 57% 48% 60% 51% 59% 54% 49% 57% 55% 58% 61% 54% 81% 46% 61% 59% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.482949
GSM549102patient 115, normal, homogenized [OPG study]5.6093951
GSM549104patient 119, normal, homogenized [OPG study]7.7693579
GSM549108patient 138, normal, homogenized [OPG study]5.748953
GSM549119patient 077, normal, homogenized [OPG study]5.7382854
GSM549133patient 032, cancer, homogenized [OPG study]5.5755852
GSM549139patient 042, cancer, homogenized [OPG study]5.9393257
GSM549099patient 107, normal, homogenized [OPG study]5.9435657
GSM549109patient 139, normal, homogenized [OPG study]5.1942244
GSM549110patient 046, normal, homogenized [OPG study]5.3679447
GSM549114patient 063, normal, homogenized [OPG study]5.4215749
GSM549122patient 082, normal, homogenized [OPG study]5.8641556
GSM549134patient 033, cancer, homogenized [OPG study]5.6145152
GSM549136patient 036, cancer, homogenized [OPG study]5.7424155
GSM549140patient 044, cancer, homogenized [OPG study]5.9098757
GSM549111patient 047, normal, homogenized [OPG study]5.7932355
GSM549113patient 057, normal, homogenized [OPG study]5.6550653
GSM549132patient 031, cancer, homogenized [OPG study]5.9330457
GSM549137patient 038, cancer, homogenized [OPG study]6.1833261
GSM549142patient 047, cancer, homogenized [OPG study]6.4510164
GSM549100patient 110, normal, homogenized [OPG study]5.7939355
GSM549107patient 135, normal, homogenized [OPG study]5.5719652
GSM549115patient 068, normal, homogenized [OPG study]5.3897449
GSM549116patient 072, normal, homogenized [OPG study]5.2368245
GSM549120patient 078, normal, homogenized [OPG study]5.5864251
GSM549131patient 030, cancer, homogenized [OPG study]5.5365951
GSM549118patient 074, normal, homogenized [OPG study]5.7174354
GSM549129patient 027, cancer, homogenized [OPG study]5.9562457
GSM549123patient 088, normal, homogenized [OPG study]5.3656148
GSM549124patient 006, cancer, homogenized [OPG study]6.147960
GSM549126patient 015, cancer, homogenized [OPG study]5.5821251
GSM549128patient 025, cancer, homogenized [OPG study]6.107359
GSM549103patient 117, normal, homogenized [OPG study]5.811454
GSM549117patient 073, normal, homogenized [OPG study]5.407449
GSM549138patient 041, cancer, homogenized [OPG study]5.9306757
GSM549141patient 045, cancer, homogenized [OPG study]5.7742855
GSM549130patient 028, cancer, homogenized [OPG study]5.9674358
GSM549101patient 111, normal, homogenized [OPG study]6.1955361
GSM549105patient 128, normal, homogenized [OPG study]5.7901654
GSM549106patient 134, normal, homogenized [OPG study]8.0938981
GSM549112patient 048, normal, homogenized [OPG study]5.2758646
GSM549125patient 011, cancer, homogenized [OPG study]6.1695561
GSM549127patient 024, cancer, homogenized [OPG study]6.0750859
GSM549135patient 035, cancer, homogenized [OPG study]5.5555751